<DOC>
	<DOCNO>NCT02150187</DOCNO>
	<brief_summary>HCap Formula compose medicinal plant , vitamin mineral . The purpose study evaluate efficacy HCap Formula , nutrition supplement promote hair growth men tendency hair loss .</brief_summary>
	<brief_title>Efficacy Nutrition Supplement Treatment Men With Hair Loss</brief_title>
	<detailed_description>This study consist treatment phase ( 6 month ) follow-up phase ( 6 month ) . Eligible subject randomly assign receive treatment study medication placebo . Subjects visit clinic 3 , 6 , 12 month treatment start safety efficacy evaluation . HCap Formula placebo tablet take orally every day 6 month .</detailed_description>
	<mesh_term>Alopecia</mesh_term>
	<mesh_term>Alopecia Areata</mesh_term>
	<criteria>1 . Healthy male 1840 year age . 2 . No abnormality blood test analysis 3 . Present mild moderate androgenic alopecia ( AGA ) grade IIv , IIIv , IV V accord HamiltonNorwood classification 4 . Willingness use shampoo , refrain change hair style , refrain hair dye study . 5 . Willingness refrain therapy affect hair study 6 . Willingness photograph treat area take . 7 . Willingness follow treatment schedule post treatment followup . 8 . Willingness participate study study course General 1 . Having know allergy ingredient test product ; 2 . Participation study another device drug within one month prior enrollment study . Hair treatments/ scalp condition 3 . Undergone hair transplant surgery , scalp reduction surgery 4 . Having hair weave tattoo alopecic area . 5 . Other hair loss disorder , alopecia areata , scar alopecia . 6 . Suffering active dermatological condition treat area scalp atrophy , opinion investigator might interfere clinical evaluation . Medications Use follow medication within past 6 month : 7 . Prescription overthecounter systemic topical treatment specific androgenic alopecia ( minoxidil , finasteride , dutasteride ) . 8 . 5Î±reductase inhibitor prostate condition ( e.g . benign prostate hyperplasia , prostate cancer ) hormone replacement therapy transgenders 9 . Medications antiandrogenic property ( cyproterone , spironolactone , ketoconazole , flutamide , progesterone , bicalutamide ) 10 . Medications potentially cause hypertrichosis ( e.g . cyclosporine , diazoxide , phenothiazine , zidovudine , tamoxifen , carpronium chloride ) , 11 . Medications potentially cause alopecia oral glucocorticoid , lithium , phenothiazine , tamoxifen . Use following medication within past 3 month : 12 . Botanicals/nutraceuticals hair growth 13 . Steroids systemic steroid 14 day ( e.g . corticosteroid , anabolic steroid ) topical steroid area hair loss . Other medical condition 14 . Suffering significant concurrent illness , cardiac disorder , diabetes ( type I II ) , uncontrolled hypertension , symptomatic hypotension , hyper/hypo thyroidism , pertinent neurological disorder . 15 . Suffering serious medical condition could adversely affect hair loss immunosuppression/immune deficiency disorder ( include HIV ) , history cancer having/undergoing form treatment active cancer , connective tissue disorder , inflammatory bowel disease 16 . As per Investigator 's discretion , physical mental condition might make unsafe subject participate study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Androgenetic Alopecia</keyword>
	<keyword>Male</keyword>
	<keyword>Baldness</keyword>
	<keyword>hair loss pattern</keyword>
</DOC>